Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of T4032 Eye Gel vs Lumigan Eye Drops in Healthy Volunteers
NCT05729594Phase 1Completed
- Sponsor
- Laboratoires Théa
- Start
- Feb 2023
- Primary completion
- Apr 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bimatoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Laboratoires Théa. Primary endpoints: Plasma concentrations of bimatoprost at Week 2, Plasma concentrations of bimatoprost free acid at Week 2 and 1 more. Started Feb 2023; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT05729594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05729594.